Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial
{{output}}
Purpose of review: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce major adverse cardiovascular events (MACE), heart failure, and mortality through undetermined mechanisms independent of glycemic control. This review ... ...
